Market research
IRMD Iradimed Co
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 1B
- P/E ratio
- 49.08
- Analyst target
- 118
- Dividend yield
- 0.8%
- Beta
- 0.91
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US46266A1097
- Market cap
- 1B
- P/E ratio
- 49.08
- Analyst target
- 118
- Dividend yield
- 0.8%
- Beta
- 0.91
About
About Iradimed Co
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the IRMD discussion.
5 years, 4 months ago
IRadimed Corporation is currently in a long term uptrend where the price is trading 20.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.8.
IRadimed Corporation's total revenue sank by 21.5% to $9M since the same quarter in the previous year.
Its net income has dropped by 80.3% to $637K since the same quarter in the previous year.
Finally, its free cash flow fell by 35.7% to $2M since the same quarter in the previous year.
Based on the above factors, IRadimed Corporation gets an overall score of 2/5.